The use of the Western Blot technique has been the gold standard to determine protein expression and to semi-quantitate this expression in cell lysates. The recent publication of a flow cytometric immunophenotyping method employing fluorescently labelled antibodies to the intracellular labelling of antigens involved in Regulated Cell Death (RCD) processes has allowed the detection of three of these processes simultaneously which gave clarity to the interpretation of the relationship between apoptosis, RIP1 dependent apoptosis and necroptosis. -ve cells detected in a previous study have undergone parthanatos or still display a negative phenotype for any cell death process.
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Introduction
The use of Western blot technology to quantitate types and levels of the various forms of regulated cell death (RCD) has been in place for decades. Although there are limitations with the technique 1, 2 there has been great advances in the understanding of the signalling pathways of apoptosis, necroptosis, RIP1-dependent apoptosis, pyroptosis, parthanatos and DNA damage and how they interact within the cell and there locations within the cells [3] [4] [5] [6] [7] [8] . One of the main criticisms of the Western Blot is the number of cells required and hence that low incidence populations will not be detected. Also all the cells are lysed and hence there is no distinguishing of live and dead cells which may show dramatically different distribution of particular RCDs. Hence the relative levels of these different types of cell populations may unduly influence the quantification of specific forms of RCDs
1
. The use of fluorescent antibodies targeted against active Caspase-3 (apoptosis), RIP3 (necroptosis), PARP (parthanatos) and H2AX (DNA damage) and a fixable cell viability allows flow cytometric analysis of such cells which removes all the issues that have questioned the value of Western Blot analysis in cell death research. Moreover, this approach gives an insight into the relative incidences of most RCDs within a single cell population revealing that as perhaps expected live cells show a very different phenotypic profile to dead cells which are very uniform no matter which RCD has been induced 9 .
Materials and methods
Jurkat cells (human acute T cell leukaemia cell line) were left untreated or treated shikonin (S, 0.5 µM) or etoposide (Etop, 1 µM) for 24 h. Cells were also pre-treated with necroptosis blocker necrostatin-1 (60 µM) and or pan-caspase blocker zVAD (20 µM) for 2 h before shikonin or etoposide treatment.
Harvested cells were labelled with fixable live dead stain, Zombie NIR (Near Infra-Red) at RT for 15 mins. Cells were then washed in PBS/BSA and pellets fixed in Solution A (CalTag) for 15 min at RT. Washed cells were permeabilised in 0.25% Triton X-100 for 15 min at RT. Washed cells (0.5 x 10 6 ) were then labelled anti-RIP3-PE and anti-active caspase-3-BV650 for 20 min at RT. Washed cells were resuspended in 400 µl PBS and analysed on a ACEA Bioscience Novocyte 3000 flow cytometer (100,000 events Figure. 1A, B) [10] [11] [12] . Shikonin a known inducer of necroptosis 13 and apoptosis ) with a small reduction in overall cell death ( Figure. 1D) 15 . Similarly zVAD reduced detectable shikonin induced apoptosis by 60% with more cells dying via a caspase-3 independent mechanism commonly termed necrosis ( Figure. 1E ) 13, 15 . Blockade of shikonin induced necroptosis by necrostatin-1 (Necro-1) caused a 40% increase in apoptosis with 38% less necrotic cell death (Caspase-3 -ve /cell viability +ve Figure. 1F) 13, 15 .
However, a major stumbling block to the process was to phenotypically define necroptosis which occurs when RIP1 up-regulates RIP3 6, 9, 13, 16 . 6, 13, 16 . These live cells also showed a high degree of apoptosis (18%), RIP1-dependent apoptosis (26%) and a double negative phenotype (24%, Figure. 3A ). Dead cells displayed a different distribution of apoptotic (33%), RIP1-dependent apoptosis (31%) and double negative phenotype (31%) compared to live cells ( Figure. 3B ) 13, 14 . The defining of the live necroptotic population (Caspase-3 -ve /RIP3 +ve ) by the up-regulation of RIP3 was confirmed by the blockade of shikonin induced necroptosis by necrostatin-1, which showed a down-regulation of RIP3 by >60% ( Figure. 3C) 
13
. Shikonin-induced apoptosis was enhanced due to blockade of the necroptosis pathway by necrostatin-1 while a similar level of RIP1-dependent apoptosis still went ahead ( Figure.  1F, 3C) . These cells also then went on to undergo cell death via apoptosis and RIP1-dependent apoptosis (Figure. . Student T-test for comparisons of treated and untreated cells P<0.05 *, <0.01 **, <0.001 *** NS -not significant, n=3.
apoptosis unlike that observed with etoposide ( Figure  3E) . Hence etoposide induced RIP1-dependent apoptosis appears to circumvent the mode of action of zVAD while shikonin did not, thus giving an insight into the signalling routes activated by the two drugs. However dead cells resulting from zVAD blockade of shikonin again showed a high degree of RIP1-dependent apoptosis (and double negative population) thus apparently circumventing this blockade of caspase-3 ( Figure. 3F) .
Enhancement of the Assay
The increased presence of live and dead cells with a double negative phenotype after use of zVAD and necrostatin-1 raised the question how were these cells dying? Is it via pyroptosis, autophagy, parthanatos or DNA damage? So following on from the recent publication of this method it has been possible to include the detection of parthanatos and DNA damage by the use of PARP and H2AX antibodies extending the assay to five colour immunophenotyping. +ve population was reduced compared to etoposide ( Figure. 4E) . This increase in live cell parthanatos was interestingly not transferred to the dead cell population which showed similar levels as that detected in dead untreated cells (Figure. 4B, F) . Hence zVAD appears to abrogate the DNA damage response but not live cell parthanatos. Interestingly, co-treatment with necrostatin-1 and etoposide resulted in the abrogation of parthanatos in live and dead cells but displayed an increase in DNA damage resulting in a higher proportion of quadruple phenotypically live negative cells ( Figure. 
Conclusion
The use of a fixable live-dead cell probe with an activecaspase-3 antibody is more informative than the classic Annexin V assay commonly used in flow cytometry as it phenotypes dead cells into late apoptotic and necrotic 9, 17 . The up-regulation of RIP3 within the live cell population is definitive for necroptosis but also allows the phenotyping of classic and RIP1-dependent apoptosis in live and dead cells 13, 16 . The distribution of these populations in live and dead cells is significantly different indicating that Western Blot results from cell lysates will be potentially grossly affected by the relative distribution of live and dead cells in any such preparations. The addition of PARP and H2AX allows further dissection of RCD processes to a finer degree not shown by any other technical approach.
Future Directions
It has also been possible to further extend the assay by the addition of antibodies to detect autophagy (LC3B), ER stress (PERK) and pyroptosis (active Caspase-1 upregulation). Interestingly autophagic cells were found to differ mainly in the level of DNA Damage which was reduced in live cells and increased in dead cells compared to untreated cells (data not shown). It is tempting to postulate that the autophagic process maintains cell health at the DNA level. Thus it is possible to simultaneously detect almost every form of RCD by this flow cytometric approach.
